Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Ferlay

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]B Chauvet, M-A Mahé, P Maingon, et al.
International Journal of Cancer|April 22, 2021
Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burdenGholamreza Roshandel, Jacques Ferlay, Ali Ghanbari-Motlagh, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]B Chauvet, M-A Mahé, P Maingon, et al.
International Journal of Cancer|April 22, 2021
Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burdenGholamreza Roshandel, Jacques Ferlay, Ali Ghanbari-Motlagh, et al.
Pageof 13